Sanofi-Synthélabo Ireland Ltd.

Sanofi-Synthélabo Ireland Ltd. currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Sanofi, and any climate commitments or emissions data would be cascaded from its parent organisation.

Sanofi has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, which focuses on renewable energy. However, specific reduction targets or achievements for Sanofi-Synthélabo Ireland Ltd. have not been detailed in the available information.

As a part of the pharmaceutical industry, Sanofi-Synthélabo Ireland Ltd. is expected to align with broader corporate sustainability goals, which typically include commitments to reduce greenhouse gas emissions across all scopes (Scope 1, 2, and 3). The lack of specific data highlights the need for ongoing transparency and accountability in their climate commitments.